Searching…
Contact Us
Site Logo
Contact Us
Back
Asset Type: Webinars, Imaging, Imaging Core Lab, Oncology

Central Imaging in Early Phase Oncology Trials

Oliver Bohnsack, MD, PhD, VP, Scientific & Medical Services, Head of Oncology
Oliver Bohnsack, MD, PhD, VP, Scientific & Medical Services, Head of Oncology
Amy Jung Hyun Lee, Ph.D, Sr. Project Manager
Amy Jung Hyun Lee, Ph.D, Sr. Project Manager
Central Imaging in Early Phase Oncology Trials

Central Imaging in Early Phase Oncology Trials

April 9, 2026 | 4:00 pm Korean Standard Time

 

Join us as Perceptive Imaging scientists review:

  • Operational benefits and key considerations when implementing central imaging in clinical studies.
  • Scientific considerations in early‑phase oncology and the critical role of BICR (Blind Independent Central Reading) in ensuring high‑quality, unbiased imaging data.
  • How BICR rolling reads enhance safety monitoring, particularly in studies with elevated risk of interstitial lung disease (ILD) in ADC drug.

 

Register now

How Can We Help?

Reach out today and one of our solution experts will be in touch to learn about your specific needs.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
By subscribing, you consent to receive emails from Perceptive. We respect your privacy and you can manage your communication preferences anytime. You can find the Perceptive privacy policy.

Logo

Stay Updated

Never miss a beat.

Sign up to receive emails covering industry news and useful content to help you advance clinical development.

© Perceptive 2025. All Rights Reserved.
Do Not Sell or Share My Personal Information